Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mupirocin for infection prevention in CABG
NCT01949935Phase 3Completed
- Sponsor
- Horizon Health Network
- Start
- Mar 2009
- Primary completion
- May 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mupirocin in surgical site infection (SSI), sponsored by Horizon Health Network. Started Mar 2009; status: completed.
02
Drugs
mupirocin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01949935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949935.